Literature DB >> 11777556

Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.

Philipp M Lenzlinger1, Andreas Marx, Otmar Trentz, Thomas Kossmann, Maria Cristina Morganti-Kossmann.   

Abstract

The mechanisms underlying cell death following traumatic brain injury (TBI) are not fully understood. Apoptosis is believed to be one mechanism contributing to a marked and prolonged neuronal cell loss following TBI. Recent data suggest a role for Fas (APO-1, CD95), a type I transmembrane receptor glycoprotein of the nerve growth factor/tumor necrosis factor superfamily, and its ligand (Fas ligand, FasL) in apoptotic events in the central nervous system. A truncated form of the Fas receptor, soluble Fas (sFas) may indicate activation of the Fas/FasL system and act as a negative feedback mechanism, thereby inhibiting Fas mediated apoptosis. Soluble Fas was measured in cerebrospinal fluid (CSF) and serum of 10 patients with severe TBI (GCS< or =8) for up to 15 days post-trauma. No sFas was detected in CSF samples from patients without neurological pathologies. Conversely, after TBI 118 out of 120 CSF samples showed elevated sFas concentrations ranging from 56 to 4327 mU/ml. Paired serum samples showed above normal (8.5 U/ml) sFas concentrations in 5 of 10 patients. Serum levels of sFas were always higher than CSF levels. However, there was no correlation between concentrations measured in CSF and in serum (r(2)=0.078, p=0.02), suggesting that the concentrations in the two compartments are independently regulated. Also, no correlation was found between sFas in CSF and blood brain barrier (BBB) dysfunction as assessed by the albumin CSF/serum quotient (Q(A)), and concentrations of the cytotoxic cytokine tumor necrosis factor-alpha in CSF, respectively. Furthermore, there was no correlation with two markers of immune activation (soluble interleukin-2 receptor and neopterin) in CSF. Maximal CSF levels of sFas correlated significantly (r(2)=0.8191, p<0.001) with the early peaks of neuron-specific enolase in CSF (a marker for neuronal cell destruction), indicating that activation of the Fas mediated pathway of apoptosis may be in part the direct result of the initial trauma. However, the prolonged elevation of sFas in CSF may be caused by the ongoing inflammatory response to trauma and delayed apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11777556     DOI: 10.1016/s0165-5728(01)00466-0

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  18 in total

Review 1.  Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.

Authors:  Jenna M Ziebell; Maria Cristina Morganti-Kossmann
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

Review 2.  Hemorrhagic progression of a contusion after traumatic brain injury: a review.

Authors:  David Kurland; Caron Hong; Bizhan Aarabi; Volodymyr Gerzanich; J Marc Simard
Journal:  J Neurotrauma       Date:  2011-12-05       Impact factor: 5.269

3.  Inflammation and immune system activation after traumatic brain injury.

Authors:  Ramani Balu
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

4.  CSF Bcl-2 and cytochrome C temporal profiles in outcome prediction for adults with severe TBI.

Authors:  Amy K Wagner; Krutika B Amin; Christian Niyonkuru; Brett A Postal; Emily H McCullough; Haishin Ozawa; C Edward Dixon; Hulya Bayir; Robert S Clark; Patrick M Kochanek; Anthony Fabio
Journal:  J Cereb Blood Flow Metab       Date:  2011-03-30       Impact factor: 6.200

Review 5.  Apoptosis and traumatic brain injury.

Authors:  Jill Wong; Ng Wai Hoe; Feng Zhiwei; Ivan Ng
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 6.  Ischemia-reperfusion injury in stroke.

Authors:  May Nour; Fabien Scalzo; David S Liebeskind
Journal:  Interv Neurol       Date:  2013-09

7.  Berberine Protects Secondary Injury in Mice with Traumatic Brain Injury Through Anti-oxidative and Anti-inflammatory Modulation.

Authors:  Shu-Xuan Huang; Guozhen Qiu; Fu-Rong Cheng; Zhong Pei; Zhi Yang; Xu-Hui Deng; Jin-Hua Zhu; Lue Chen; Chun-Chun Chen; Wei-Feng Lin; Yuan Liu; Zhengshan Liu; Fei-Qi Zhu
Journal:  Neurochem Res       Date:  2018-07-19       Impact factor: 3.996

8.  Distinct roles of trauma and transfusion in induction of immune modulation after injury.

Authors:  Rachael P Jackman; Garth H Utter; Marcus O Muench; John W Heitman; Matthew M Munz; Robert W Jackman; Hope H Biswas; Ryan M Rivers; Leslie H Tobler; Michael P Busch; Philip J Norris
Journal:  Transfusion       Date:  2012-03-27       Impact factor: 3.157

9.  Detectable levels of cytochrome C and activated caspase-9 in cerebrospinal fluid after human traumatic brain injury.

Authors:  Ribal S Darwish; Nana S Amiridze
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

Review 10.  Triggers and mediators of hemorrhagic transformation in cerebral ischemia.

Authors:  Xiaoying Wang; Eng H Lo
Journal:  Mol Neurobiol       Date:  2003-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.